Abstract
Sigma-1 receptor (Sig-1R) is a protein present in several organs such as brain, lung, and heart. In a cell, Sig-1R is mainly located across the membranes of the endoplasmic reticulum and more specifically at the mitochondria-associated membranes. Despite numerous studies showing that Sig-1R could be targeted to rescue several cellular mechanisms in different pathological conditions, less is known about its fundamental relevance. In this review, we report results from various studies and focus on the importance of Sig-1R in physiological conditions by comparing Sig-1R KO mice to wild-type mice in order to investigate the fundamental functions of Sig-1R. We note that the Sig-1R deletion induces cognitive, psychiatric, and motor dysfunctions, but also alters metabolism of heart. Finally, taken together, observations from different experiments demonstrate that those dysfunctions are correlated to poor regulation of ER and mitochondria metabolism altered by stress, which could occur with aging.
Similar content being viewed by others
Abbreviations
- AAV:
-
Adeno-associated virus
- ACTH:
-
Adrenocorticotropic hormone
- AD:
-
Alzheimer’s disease
- Ala:
-
Alamine
- ALS:
-
Amyotrophic lateral sclerosis
- AMRS:
-
Acute mild restraint stress
- ATP:
-
Adenosine triphosphate
- BiP:
-
Binding immunoglobulin protein
- CA1:
-
Cornu Ammonis 1
- cAMP:
-
Cyclic adenosine monophosphate
- CD1:
-
Capsaicin sensitized
- CNS:
-
Central nervous system
- CPS1:
-
Carbamoyl phosphate synthetase I
- CREB:
-
cAMP response element-binding protein
- CRF:
-
Corticotropin-releasing factor
- DG:
-
Dentate gyrus
- DMT:
-
N,N-dimethyltryptamine
- DRG:
-
Dorsal root ganglion
- eGFP:
-
Enhanced GFP
- ERK1/2:
-
Extracellular signal-regulated kinases 1 and 2
- FST:
-
Forced swim test
- GFP:
-
Green fluorescent protein
- Gln:
-
Glutamine
- Glu:
-
Glutamic acid
- GRP78:
-
78-kDa glucose-regulated protein
- GSSG:
-
Oxidized glutathione
- HD:
-
Huntington’s disease
- HPA:
-
Hypothalamic pituitary adrenal
- HSP5:
-
Heat shock protein 5
- IP3R:
-
Inositol trisphosphate receptor
- IRE1:
-
Inositol-requiring enzyme 1
- KD:
-
Knockdown
- KO:
-
Knockout
- MAM:
-
Mitochondria-associated membranes
- mRNA:
-
Messenger RNA
- Mups:
-
Major urinary proteins
- NMDA:
-
N-methyl-d-aspartate
- NMDAr:
-
NMDA receptor
- NR2B:
-
NMDA receptor subtype 2B
- OVX:
-
Ovariectomizing
- PD:
-
Parkinson’s disease
- pERK1/2:
-
Phosphorylated ERK1/2
- PET:
-
Positron emission tomography
- PKA:
-
Protein kinase A
- PKC:
-
Protein kinase C
- PMA:
-
Phorbol 12-myristate 13-acetate
- PP2:
-
4-Amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine
- Prdx6:
-
Peroxiredoxin-6
- PSNL:
-
Partial sciatic nerve ligation
- PVN:
-
Paraventricular nucleus of the hypothalamus
- ROS:
-
Reactive oxygen speices
- SCI:
-
Spinal cord contusion injury
- Sig-1R:
-
Sigma-1 receptor
- SKF:
-
Alazocine
- STPA:
-
Step-through passive avoidance
- Thr:
-
Threonine
- TRPV1:
-
Transient receptor potential cation channel, subfamily V, member 1
- TST:
-
Tail suspension test
- Val:
-
Valine
- WT:
-
Wild-type
- XBP1:
-
X-box binding protein 1
- YMT:
-
Y-maze test
References
Abdullah CS et al (2018) Cardiac dysfunction in the sigma 1 receptor knockout mouse associated with impaired mitochondrial dynamics and bioenergetics. J Am Heart Assoc. https://doi.org/10.1161/jaha.118.009775
Akunne HC, Zoski KT, Whetzel SZ, Cordon JJ, Brandon RM, Roman F, Pugsley TA (2001) Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant. Neuropharmacology 41:138–149. https://doi.org/10.1016/s0028-3908(01)00049-1
Alam S et al (2017) Sigmar1 regulates endoplasmic reticulum stress-induced C/EBP-homologous protein expression in cardiomyocytes. Biosci Rep 37:BSR20170898. https://doi.org/10.1042/bsr20170898
Alonso G, Phan VL, Guillemain I, Saunier M, Legrand A, Anoal M, Maurice T (2000) Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system. Neuroscience 97:155–170. https://doi.org/10.1016/s0306-4522(00)00014-2
Al-Saif A, Al-Mohanna F, Bohlega S (2011) A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol 70:913–919. https://doi.org/10.1002/ana.22534
Baum E et al (2017) PET imaging evaluation of four σ1 radiotracers in nonhuman primates. J Nucl Med 58:982–988. https://doi.org/10.2967/jnumed.116.188052
Benedict PE, Benedict MB, Su TP, Bolling SF (1999) Opiate drugs and -receptor-mediated myocardial protection. Circulation 100:357–360. https://doi.org/10.1161/01.cir.100.suppl_2.ii-357
Bernard-Marissal N, Médard J-J, Azzedine H, Chrast R (2015) Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration. Brain 138:875–890. https://doi.org/10.1093/brain/awv008
Bhuiyan MS, Fukunaga K (2011) Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection. Expert Opin Ther Targets 15:145–155. https://doi.org/10.1517/14728222.2011.546350
Bhuiyan MS, Tagashira H, Fukunaga K (2011) Sigma-1 receptor stimulation with fluvoxamine activates Akt–eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. Eur J Pharmacol 650:621–628. https://doi.org/10.1016/j.ejphar.2010.10.055
Blasio A et al (2015) Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats. Behav Brain Res 287:315–322. https://doi.org/10.1016/j.bbr.2015.03.065
Bolshakova AV, Kukanova EO, Gainullina AN, Zhemkov VA, Korban SA, Bezprozvanny IB (2016) Sigma-1 receptor as a potential pharmacological target for the treatment of neuropathology St Petersburg Polytechnical University. J: Phys Math 2:31–40. https://doi.org/10.1016/j.spjpm.2016.03.003
Boyette-Davis JA et al (2013) Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine. Cancer Chemother Pharmacol 71:619–626. https://doi.org/10.1007/s00280-012-2047-z
Bravo-Caparrós I, Perazzoli G, Yeste S, Cikes D, Baeyens JM, Cobos EJ, Nieto FR (2019) Sigma-1 receptor inhibition reduces neuropathic pain induced by partial sciatic nerve transection in mice by opioid-dependent and -independent mechanisms. Front Pharmacol 10:613. https://doi.org/10.3389/fphar.2019.00613
Bravo-Caparrós I et al (2020) Sigma-1 receptors control neuropathic pain and macrophage infiltration into the dorsal root ganglion after peripheral nerve injury. FASEB J 34:5951–5966. https://doi.org/10.1096/fj.201901921r
Castany S, Gris G, Vela JM, Verdú E, Boadas-Vaello P (2018) Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice. Sci Rep 8:3873. https://doi.org/10.1038/s41598-018-22217-9
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824. https://doi.org/10.1038/39807
Cendán CM, Pujalte JM, Portillo-Salido E, Montoliu L, Baeyens JM (2005) Formalin-induced pain is reduced in σ1 receptor knockout mice. Eur J Pharmacol 511:73–74. https://doi.org/10.1016/j.ejphar.2005.01.036
Chao J, Zhang Y, Du L, Zhou R, Wu X, Shen K, Yao H (2017) Molecular mechanisms underlying the involvement of the sigma-1 receptor in methamphetamine-mediated microglial polarization. Sci Rep 7:11540. https://doi.org/10.1038/s41598-017-11065-8
Chevallier N, Keller E, Maurice T (2011) Behavioural phenotyping of knockout mice for the sigma-1 (σ1) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations. J Psychopharmacol 25:960–975. https://doi.org/10.1177/0269881111400648
Chien CC, Pasternak GW (1993) Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid σ1 system. Eur J Pharmacol 250:R7–R8. https://doi.org/10.1016/0014-2999(93)90650-7
Christ MG, Huesmann H, Nagel H, Kern A, Behl C (2019) Sigma-1 receptor activation induces autophagy and increases proteostasis capacity in vitro and in vivo. Cells 8:1. https://doi.org/10.3390/cells8030211
Couly S, Khalil B, Viguier V, Roussel J, Maurice T, Liévens J-C (2019) Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis. Hum Mol Genet. https://doi.org/10.1093/hmg/ddz267
Crouzier L et al (2020) Sigma-1 (σ1) receptor activity is necessary for physiological brain plasticity in mice. Eur Neuropsychopharmacol 39:29–45. https://doi.org/10.1016/j.euroneuro.2020.08.010
Deuis JR, Dvorakova LS, Vetter I (2017) Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci 10:284. https://doi.org/10.3389/fnmol.2017.00284
Di T, Zhang S, Hong J, Zhang T, Chen L (2017) Hyperactivity of hypothalamic-pituitary-adrenal axis due to dysfunction of the hypothalamic glucocorticoid receptor in sigma-1 receptor knockout mice. Front Mol Neurosci 10:287. https://doi.org/10.3389/fnmol.2017.00287
Dreser A et al (2017) The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ 24:1655–1671. https://doi.org/10.1038/cdd.2017.88
Dumont M, Lemaire S (1991) Interaction of 1,3-di(2-[5-3H]tolyl)guanidine with σ2 binding sites in rat heart membrane preparations. Eur J Pharmacol 209:245–248. https://doi.org/10.1016/0014-2999(91)90176-q
Eisner V, Picard M, Hajnóczky G (2018) Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat Cell Biol 20:755–765. https://doi.org/10.1038/s41556-018-0133-0
Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y (1994) Sigma receptor ligands modulate contractility, Ca ++ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 269:1300–1309
Entrena JM et al (2009) Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain 143:252–261. https://doi.org/10.1016/j.pain.2009.03.011
Fagerberg L et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteom 13:397–406. https://doi.org/10.1074/mcp.m113.035600
Fehér Á, Juhász A, László A, Kálmán J, Pákáski M, Kálmán J, Janka Z (2012) Association between a variant of the sigma-1 receptor gene and Alzheimer’s disease. Neurosci Lett 517:136–139. https://doi.org/10.1016/j.neulet.2012.04.046
Fischer M, Carli G, Raboisson P, Reeh P (2014) The interphase of the formalin test. Pain 155:511–521. https://doi.org/10.1016/j.pain.2013.11.015
Fisher A et al (2016) AF710B, a novel M1/σ1 agonist with therapeutic efficacy in animal models of Alzheimer’s disease. Neurodegener Dis 16:95–110. https://doi.org/10.1159/000440864
Foley JW, Bercury SD, Finn P, Cheng SH, Scheule RK, Ziegler RJ (2010) Evaluation of systemic follistatin as an adjuvant to stimulate muscle repair and improve motor function in pompe mice. Mol Ther 18:1584–1591. https://doi.org/10.1038/mt.2010.110
Fonken LK, Frank MG, Gaudet AD, Maier SF (2018) Stress and aging act through common mechanisms to elicit neuroinflammatory priming Brain. Behav Immun 73:133–148. https://doi.org/10.1016/j.bbi.2018.07.012
Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009) The hallucinogen N, N-dimethyltryptamine (DMT) Is an endogenous sigma-1 receptor regulator. Science 323:934–937. https://doi.org/10.1126/science.1166127
Francardo V, Bez F, Wieloch T, Nissbrandt H, Ruscher K, Cenci MA (2014) Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain 137:1998–2014. https://doi.org/10.1093/brain/awu107
Francardo V, Geva M, Bez F, Denis Q, Steiner L, Hayden MR, Cenci MA (2019) Pridopidine induces functional neurorestoration via the sigma-1 receptor in a mouse model of Parkinson’s disease. Neurotherapeutics 16:465–479. https://doi.org/10.1007/s13311-018-00699-9
Gill JF, Santos G, Schnyder S, Handschin C (2018) PGC-1α affects aging-related changes in muscle and motor function by modulating specific exercise-mediated changes in old mice. Aging Cell 17:e12697. https://doi.org/10.1111/acel.12697
Gjerstad JK, Lightman SL, Spiga F (2018) Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress 21:403–416. https://doi.org/10.1080/10253890.2018.1470238
Glennon RA, Ablordeppey SY, Ismaiel AM, El-Ashmawy MB, Fischer JB, Howie KB (1994) Structural features important for sigma 1 receptor binding. J Med Chem 37:1214–1219. https://doi.org/10.1021/jm00034a020
Goguadze N, Zhuravliova E, Morin D, Mikeladze D, Maurice T (2019) Sigma-1 receptor agonists induce oxidative stress in mitochondria and enhance complex I activity in physiological condition but protect against pathological oxidative stress. Neurotox Res 35:1–18. https://doi.org/10.1007/s12640-017-9838-2
González-Cano R et al (2020) Urinary bladder sigma-1 receptors: a new target for cystitis treatment. Pharmacol Res 155:104724. https://doi.org/10.1016/j.phrs.2020.104724
Green AS, Grahame NJ (2008) Ethanol drinking in rodents: is free-choice drinking related to the reinforcing effects of ethanol? Alcohol 42:1–11. https://doi.org/10.1016/j.alcohol.2007.10.005
Gregianin E et al (2016) Loss-of-function mutations in the SIGMAR1 gene cause distal hereditary motor neuropathy by impairing ER-mitochondria tethering and Ca2+ signalling. Hum Mol Genet 25:3741–3753. https://doi.org/10.1093/hmg/ddw220
Gregory NS, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA (2013) An overview of animal models of pain: disease models and outcome measures. J Pain 14:1255–1269. https://doi.org/10.1016/j.jpain.2013.06.008
Guzmán A, Marín A-P, García C, de Henestrosa ARF, Ruiz MT, Tortajada A, Marcos R (2008) Induction of hypothermic conditions associated with increased micronuclei formation in sigma-1 receptor knockout mice after administration of the antipsychotic compound E-5842. Environ Mol Mutagen 49:727–733. https://doi.org/10.1002/em.20428
Ha Y et al (2011) Late-onset inner retinal dysfunction in mice lacking sigma receptor 1 (σR1). Investig Ophthalmol Vis Sci 52:7749–7760. https://doi.org/10.1167/iovs.11-8169
Ha Y, Saul A, Tawfik A, Zorrilla EP, Ganapathy V, Smith SB (2012) Diabetes accelerates retinal ganglion cell dysfunction in mice lacking sigma receptor 1. Mol Vis 18:2860–2870
Haigis MC, Yankner BA (2010) The aging stress response. Mol Cell 40:333–344. https://doi.org/10.1016/j.molcel.2010.10.002
Ham H, Woolery AR, Tracy C, Stenesen D, Krämer H, Orth K (2014) Unfolded protein response-regulated Drosophila Fic (dFic) Protein reversibly AMPylates BiP chaperone during endoplasmic reticulum homeostasis. J Biol Chem 289:36059–36069. https://doi.org/10.1074/jbc.m114.612515
Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 93:8072–8077. https://doi.org/10.1073/pnas.93.15.8072
Hayashi T, Su TP (2001) Regulating ankyrin dynamics: roles of sigma-1 receptors. Proc Natl Acad Sci USA 98:491–496. https://doi.org/10.1073/pnas.021413698
Hayashi T, Su T-P (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 131:596–610. https://doi.org/10.1016/j.cell.2007.08.036
Hayashi T et al (2010) Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats. J Pharmacol Exp Ther 332:1054–1063. https://doi.org/10.1124/jpet.109.159244
Hellewell SB, Bowen WD (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res 527:244–253. https://doi.org/10.1016/0006-8993(90)91143-5
Hong J, Sha S, Zhou L, Wang C, Yin J, Chen L (2015) Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons. Cell Death Dis 6:e1832. https://doi.org/10.1038/cddis.2015.194
Hong J, Wang L, Zhang T, Zhang B, Chen L (2017) Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra. Neurobiol Aging 59:171–183. https://doi.org/10.1016/j.neurobiolaging.2017.08.007
Huang Z-Q, Shi G-G, Zheng J-H, Liu B (2003) Effects of N-n-butyl haloperidol iodide on rat myocardial ischemia and reperfusion injury and L-type calcium current. Acta Pharmacol Sin 24:757–763
Huang Y et al (2011) Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimers disease. CAR 8:765–770. https://doi.org/10.2174/156720511797633232
Ionescu A et al (2019) Targeting the sigma-1 receptor via pridopidine ameliorates central features of ALS pathology in a SOD1G93A model. Cell Death Dis 10:210. https://doi.org/10.1038/s41419-019-1451-2
Jabłońska M, Grzelakowska K, Wiśniewski B, Mazur E, Leis K, Gałązka P (2020) Pridopidine in the treatment of Huntington’s disease. Rev Neurosci. https://doi.org/10.1515/revneuro-2019-0085
James ML et al (2012) New positron emission tomography (PET) radioligand for imaging σ-1 receptors in living subjects. J Med Chem 55:8272–8282. https://doi.org/10.1021/jm300371c
Johannessen M, Ramachandran S, Riemer L, Ramos-Serrano A, Ruoho AE, Jackson MB (2009) Voltage-gated sodium channel modulation by σ-receptors in cardiac myocytes and heterologous systems. Am J Physiol Cell Physiol 296:C1049–C1057. https://doi.org/10.1152/ajpcell.00431.2008
Kekuda R, Prasad PD, Fei Y-J, Leibach FH, Ganapathy V (1996) Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 229:553–558. https://doi.org/10.1006/bbrc.1996.1842
Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R (2000) Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat 20:375–387. https://doi.org/10.1016/s0891-0618(00)00106-x
Kotitschke A, Sadie-Van Gijsen H, Avenant C, Fernandes S, Hapgood JP (2009) Genomic and nongenomic cross talk between the gonadotropin-releasing hormone receptor and glucocorticoid receptor signaling pathways. Mol Endocrinol 23:1726–1745. https://doi.org/10.1210/me.2008-0462
Kourrich S, Hayashi T, Chuang J-Y, Tsai S-Y, Su T-P, Bonci A (2013) Dynamic interaction between sigma-1 receptor and Kv12 shapes neuronal and behavioral responses to cocaine. Cell 152:236–247. https://doi.org/10.1016/j.cell.2012.12.004
Lan Y et al (2019) Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET). Acta Pharm Sin B 9:1204–1215. https://doi.org/10.1016/j.apsb.2019.07.002
Langa F et al (2003) Generation and phenotypic analysis of sigma receptor type I (sigma1) knockout mice. Eur J Neurosci 18:2188–2196. https://doi.org/10.1046/j.1460-9568.2003.02950.x
Lee A-H, Iwakoshi NN, Glimcher LH (2003) XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 23:7448–7459. https://doi.org/10.1128/mcb.23.21.7448-7459.2003
Lewis R, Li J, McCormick PJ, Huang L-HC, Jeevaratnam K (2020) Is the sigma-1 receptor a potential pharmacological target for cardiac pathologies? A systematic review. IJC Heart Vasc 26:100449. https://doi.org/10.1016/j.ijcha.2019.100449
Li X et al (2015) A SIGMAR1 splice-site mutation causes distal hereditary motor neuropathy. Neurology 84:2430–2437. https://doi.org/10.1212/wnl.0000000000001680
Luty AA et al (2010) Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol 68:639–649. https://doi.org/10.1002/ana.22274
Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532
Matsuno K, Kobayashi T, Tanaka MK, Mita S (1996) σ1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol 312:267–271. https://doi.org/10.1016/0014-2999(96)00497-9
Maurice T, Privat A (1997) SA4503, a novel cognitive enhancer with σ1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. Eur J Pharmacol 328:9–18. https://doi.org/10.1016/s0014-2999(97)83020-8
Maurice T, Casalino M, Lacroix M, Romieu P (2003) Involvement of the sigma1 receptor in the motivational effects of ethanol in mice. Pharmacol Biochem Behav 74:869–876. https://doi.org/10.1016/s0091-3057(03)00002-9
Maurice T, Strehaiano M, Duhr F, Chevallier N (2018) Amyloid toxicity is enhanced after pharmacological or genetic invalidation of the σ1 receptor. Behav Brain Res 339:1–10. https://doi.org/10.1016/j.bbr.2017.11.010
Maurice T et al (2019) Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer’s disease by positive modulation of σ1 receptors. Pharmacol Res 144:315–330. https://doi.org/10.1016/j.phrs.2019.04.026
Mavlyutov TA, Epstein ML, Andersen KA, Ziskind-Conhaim L, Ruoho AE (2010) The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 167:247–255. https://doi.org/10.1016/j.neuroscience.2010.02.022
Mavlyutov TA, Nickells RW, Guo L-W (2011) Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor. Mol Vis 17:1034–1043
Mavlyutov TA, Epstein ML, Verbny YI, Huerta MS, Zaitoun I, Ziskind-Conhaim L, Ruoho AE (2013) Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience 240:129–134. https://doi.org/10.1016/j.neuroscience.2013.02.035
Mavlyutov TA, Duellman T, Kim HT, Epstein ML, Leese C, Davletov BA, Yang J (2016) Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody. Neuroscience 331:148–157. https://doi.org/10.1016/j.neuroscience.2016.06.030
Meunier J, Ieni J, Maurice T (2006) Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas. J Pharmacol Exp Ther 317:1307–1319. https://doi.org/10.1124/jpet.106.101527
Montilla-García Á, Perazzoli G, Tejada MÁ, González-Cano R, Sánchez-Fernández C, Cobos EJ, Baeyens JM (2018) Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: contribution of sigma-1 receptors. Neuropharmacology 135:328–342
Mori T, Hayashi T, Hayashi E, Su T-P (2013) Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS ONE 8:e76941. https://doi.org/10.1371/journal.pone.0076941
Moriyama Y et al (2000) The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity1. J Clin Endocrinol Metab 85:1834–1840. https://doi.org/10.1210/jcem.85.5.6568
Mysona BA, Zhao J, Smith S, Bollinger KE (2018) Relationship between Sigma-1 receptor and BDNF in the visual system. Exp Eye Res 167:25–30. https://doi.org/10.1016/j.exer.2017.10.012
Navarro G et al (2013) Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers. PLoS ONE 8:e61245. https://doi.org/10.1371/journal.pone.0061245
Nieto FR et al (2012) Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice. J Pain 13:1107–1121. https://doi.org/10.1016/j.jpain.2012.08.006
Nieto FR, Cendán CM, Cañizares FJ, Cubero MA, Vela JM, Fernández-Segura E, Baeyens JM (2014) Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice. Mol Pain. https://doi.org/10.1186/1744-8069-10-11
Novakova M, Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y (1995) Inotropic action of σ receptor ligands in isolated cardiac myocytes from adult rats. Eur J Pharmacol 286:19–30. https://doi.org/10.1016/0014-2999(95)00424-j
Novakova M, Ela C, Bowen WD, Hasin Y, Eilam Y (1998) Highly selective σ receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes. Eur J Pharmacol 353:315–327. https://doi.org/10.1016/s0014-2999(98)00398-7
Novakova M et al (2007) Modulation of expression of the sigma receptors in the heart of rat and mouse in normal and pathological conditions. Gen Physiol Biophys 26:110–117
Ossa F, Schnell JR, Ortega-Roldan JL (2017) A review of the human sigma-1 receptor structure. In: Smith SB, Su T-P (eds) Sigma receptors: their role in disease and as therapeutic targets, vol 964. Springer, Cham, pp 15–29
Pal A, Fontanilla D, Gopalakrishnan A, Chae Y-K, Markley JL, Ruoho AE (2012) The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. Eur J Pharmacol 682:12–20. https://doi.org/10.1016/j.ejphar.2012.01.030
Palmer CP, Mahen R, Schnell E, Djamgoz MBA, Aydar E (2007) Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res 67:11166–11175. https://doi.org/10.1158/0008-5472.can-07-1771
Peviani M et al (2014) Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiol Dis 62:218–232
Puente BDL et al (2009) Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury. Pain 145:294–303. https://doi.org/10.1016/j.pain.2009.05.013
Ramachandran S, Chu UB, Mavlyutov TA, Pal A, Pyne S, Ruoho AE (2009) The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. Eur J Pharmacol 609:19–26. https://doi.org/10.1016/j.ejphar.2009.03.003
Ruffolo RR (1987) Review: the pharmacology of dobutamine. Am J Med Sci 294:244–248. https://doi.org/10.1097/00000441-198710000-00005
Ryskamp D, Wu J, Geva M, Kusko R, Grossman I, Hayden M, Bezprozvanny I (2017) The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease. Neurobiol Dis 97:46–59. https://doi.org/10.1016/j.nbd.2016.10.006
Ryskamp DA, Korban S, Zhemkov V, Kraskovskaya N, Bezprozvanny I (2019) Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases. Front Neurosci 13:862. https://doi.org/10.3389/fnins.2019.00862
Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP (2009a) Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res 198:472–476. https://doi.org/10.1016/j.bbr.2008.11.036
Sabino V et al (2009b) The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking. Neuropsychopharmacology 34:1482–1493. https://doi.org/10.1038/npp.2008.192
Sabino V, Cottone P, Zhao Y, Steardo L, Koob GF, Zorrilla EP (2009c) Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist. Psychopharmacology 205:327–335. https://doi.org/10.1007/s00213-009-1548-x
Sánchez-Fernández C et al (2014) Modulation of peripheral μ-opioid analgesia by σ1 receptors. J Pharmacol Exp Ther 348:32–45. https://doi.org/10.1124/jpet.113.208272
Seth P, Leibach FH, Ganapathy V (1997) Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun 241:535–540. https://doi.org/10.1006/bbrc.1997.7840
Seth P, Ganapathy ME, Conway SJ, Bridges CD, Smith SB, Casellas P, Ganapathy V (2001) Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. Biochim Biophys Acta 1540:59–67. https://doi.org/10.1016/s0167-4889(01)00117-3
Sha S, Qu W-J, Li L, Lu Z-H, Chen L, Yu W-F, Chen L (2013) Sigma-1 receptor knockout impairs neurogenesis in dentate gyrus of adult hippocampus via down-regulation of NMDA receptors. CNS Neurosci Ther 19:705–713. https://doi.org/10.1111/cns.12129
Sha S, Hong J, Qu W-J, Lu Z-H, Li L, Yu W-F, Chen L (2015) Sex-related neurogenesis decrease in hippocampal dentate gyrus with depressive-like behaviors in sigma-1 receptor knockout mice. Eur Neuropsychopharm 25:1275–1286. https://doi.org/10.1016/j.euroneuro.2015.04.021
Shan Y, Sun S, Yang X, Weil MH, Tang W (2010) Opioid receptor agonist reduces myocardial ischemic injury when administered during early phase of myocardial ischemia. Resuscitation 81:761–765. https://doi.org/10.1016/j.resuscitation.2010.02.014
Si D et al (2014) Progesterone protects blood-brain barrier function and improves neurological outcome following traumatic brain injury in rats. Exp Ther Med 8:1010–1014. https://doi.org/10.3892/etm.2014.1840
Sigma receptors (2007) Springer, Boston
Silverman JD, Kruger L (1990) Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markers. J Neurocytol 19:789–801. https://doi.org/10.1007/bf01188046
Snyder MA, McCann K, Lalande MJ, Thivierge J-P, Bergeron R (2016) Sigma receptor type 1 knockout mice show a mild deficit in plasticity but no significant change in synaptic transmission in the CA1 region of the hippocampus. J Neurochem 138:700–709. https://doi.org/10.1111/jnc.13695
Spencer RL, Deak T (2017) A users guide to HPA axis research. Physiol Behav 178:43–65. https://doi.org/10.1016/j.physbeh.2016.11.014
Su TP (1982) Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther 223:284–290
Su TP, London ED, Jaffe JH (1988) Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 240:219–221. https://doi.org/10.1126/science.2832949
Su D-A et al (2014) Effects of BD1047, a σ1 receptor antagonist, on the expression of mTOR, Camk2γ and GSK-3β in fluvoxamine-treated N2a cells. Exp Ther Med 7:435–438. https://doi.org/10.3892/etm.2013.1438
Su T-P, Su T-C, Nakamura Y, Tsai S-Y (2016) The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol Sci 37:262–278. https://doi.org/10.1016/j.tips.2016.01.003
Tagashira H, Bhuiyan S, Shioda N, Hasegawa H, Kanai H, Fukunaga K (2010) σ1-Receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart Circ Physiol 299:H1535–H1545. https://doi.org/10.1152/ajpheart.00198.2010
Tarabová B, Nováková M, Lacinová Ľ (2009) Haloperidol moderately inhibits cardiovascular L-type calcium current. Gen Physiol Biophys 28:249–259. https://doi.org/10.4149/gpb_2009_03_249
Tsai S-Y et al (2009) Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1·GTP pathway. Proc Natl Acad Sci 106:22468–22473. https://doi.org/10.1073/pnas.0909089106
Tsai S-Y, Rothman RK, Su T-P (2012) Insights into the sigma-1 receptor Chaperone’s cellular functions: a microarray report. Synapse 66:42–51. https://doi.org/10.1002/syn.20984
Tsai S-YA, Pokrass MJ, Klauer NR, De Credico NE, Su T-P (2014) Sigma-1 receptor chaperones in neurodegenerative and psychiatric disorders. Expert Opin Ther Targets. https://doi.org/10.1517/14728222.2014.972939
Tsai S-YA, Pokrass MJ, Klauer NR, Nohara H, Su T-P (2015) Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid. Proc Natl Acad Sci 112:6742–6747. https://doi.org/10.1073/pnas.1422001112
Ukai M (1998) Beneficial effects of acute and repeated administrations of σ receptor agonists on behavioral despair in mice exposed to tail suspension. Pharmacol Biochem Behav 61:247–252. https://doi.org/10.1016/s0091-3057(98)00093-8
Ullah MI et al (2015) In silico analysis of SIGMAR1 variant (rs4879809) segregating in a consanguineous Pakistani family showing amyotrophic lateral sclerosis without frontotemporal lobar dementia. Neurogenetics 16:299–306. https://doi.org/10.1007/s10048-015-0453-1
Valenza M, DiLeo A, Steardo L, Cottone P, Sabino V (2016) Ethanol-related behaviors in mice lacking the sigma-1 receptor. Behav Brain Res 297:196–203. https://doi.org/10.1016/j.bbr.2015.10.013
Vavers E, Zvejniece L, Maurice T, Dambrova M (2019) Allosteric modulators of sigma-1 receptor: a review. Front Pharmacol 10:223. https://doi.org/10.3389/fphar.2019.00223
Venkatesh K, Hasan G (1997) Disruption of the IP3 receptor gene of Drosophila affects larval metamorphosis and ecdysone release. Curr Biol 7:500–509. https://doi.org/10.1016/s0960-9822(06)00221-1
Wagner CK (2006) The many faces of progesterone: a role in adult and developing male brain. Front Neuroendocrinol 27:340–359. https://doi.org/10.1016/j.yfrne.2006.07.003
Walter L, Hajnóczky G (2005) Mitochondria and endoplasmic reticulum: the lethal interorganelle cross-talk. J Bioenerg Biomembr 37:191–206. https://doi.org/10.1007/s10863-005-6600-x
Wang J, Mack AL, Coop A, Matsumoto RR (2007) Novel sigma (σ) receptor agonists produce antidepressant-like effects in mice. Eur Neuropsychopharmacol 17:708–716. https://doi.org/10.1016/j.euroneuro.2007.02.007
Wang J, Shanmugam A, Markand S, Zorrilla E, Ganapathy V, Smith SB (2015) Sigma 1 receptor regulates the oxidative stress response in primary retinal Müller glial cells via NRF2 signaling and system xc −, the Na + -independent glutamate–cystine exchanger. Free Radic Biol Med 86:25–36. https://doi.org/10.1016/j.freeradbiomed.2015.04.009
Xiong J et al (2020) Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain. Eur J Med Chem 191:112144. https://doi.org/10.1016/j.ejmech.2020.112144
Xu Q, Ji X-F, Chi T-Y, Liu P, Jin G, Chen L, Zou L-B (2017) Sigma-1 receptor in brain ischemia/reperfusion: possible role in the NR2A-induced pathway to regulate brain-derived neurotrophic factor. J Neurol Sci 376:166–175. https://doi.org/10.1016/j.jns.2017.03.027
Yang K, Wang C, Sun T (2019) The roles of intracellular Chaperone proteins, sigma receptors, in Parkinson’s disease (PD) and major depressive disorder (MDD). Front Pharmacol 10:528. https://doi.org/10.3389/fphar.2019.00528
Yin J et al (2015) Sigma-1 (σ1) receptor deficiency reduces β-amyloid25–35-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B. Neuropharmacology 89:215–224. https://doi.org/10.1016/j.neuropharm.2014.09.027
Zajączkowska R, Kocot-Kępska M, Leppert W, Wrzosek A, Mika J, Wordliczek J (2019) Mechanisms of chemotherapy-induced peripheral neuropathy IJMS 20:1451. https://doi.org/10.3390/ijms20061451
Zhang Y et al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34:11929. https://doi.org/10.1523/jneurosci.1860-14.2014
Zhang S, Hong J, Zhang T, Wu J, Chen L (2017) Activation of sigma-1 receptor alleviates postpartum estrogen withdrawal-induced “depression” through restoring hippocampal nNOS-NO-CREB activities in mice. Mol Neurobiol 54:3017–3030. https://doi.org/10.1007/s12035-016-9872-8
Acknowledgements
This research was supported by the Intramural Research Program of the National Institute on Drug Abuse and the National Institutes of Health. We would also like to thank Dr. Mary Pfeiffer and Dr. Jean-Charles Lievens for their corrections.
Funding
The authors were supported by the Intramural research program NIDA, NIH/DHHS.
Author information
Authors and Affiliations
Contributions
SC proposed the topic. SC and NG initiated the work. All authors reviewed the literature, drafted parts of the manuscript and revised it. All authors approved the submitted version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Couly, S., Goguadze, N., Yasui, Y. et al. Knocking Out Sigma-1 Receptors Reveals Diverse Health Problems. Cell Mol Neurobiol 42, 597–620 (2022). https://doi.org/10.1007/s10571-020-00983-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-020-00983-3